Literature DB >> 10814901

The serum nitric oxide levels in patients with Duchenne muscular dystrophy.

K Gücüyener1, E Ergenekon, D Erbas, G Pinarli, A Serdaroğlu.   

Abstract

Nitric oxide is formed in skeletal muscle by the neuronal type nitric oxide synthase and the signalling function of dystrophin and related compounds are in part mediated by nitric oxide. Duchenne muscular dystrophy, mdx mice and patients with Becker dystrophy demonstrated neuronal type nitric oxide synthase deficiency in muscle biopsy specimens. We have intended to find out whether the plasma nitric oxide levels show any abnormality in patients with Duchenne muscular dystrophy. Serum NO levels of Duchenne patients (4.191+/-2.82 micromol/l) were significantly lower than those of the control (39.53+/-19.43 micromol/l) and cerebral palsy (77.84+/-21.70 micromol/l) groups.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10814901     DOI： 10.1016/s0387-7604(00)00106-6

Source DB:  PubMed          Journal:  Brain Dev        ISSN： 0387-7604            Impact factor:   1.961


  9 in total

Review 1.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

2.  Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

Authors:  Bo Deng; David Glanzman; James G Tidball
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 3.  Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy.

Authors:  James G Tidball; Michelle Wehling-Henricks
Journal:  J Physiol       Date:  2014-09-05       Impact factor: 5.182

4.  Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.

Authors:  Roberta Buono; Chiara Vantaggiato; Viviana Pisa; Emanuele Azzoni; Maria Teresa Bassi; Silvia Brunelli; Clara Sciorati; Emilio Clementi
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

5.  Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation.

Authors:  Clara De Palma; Federica Morisi; Sarah Pambianco; Emma Assi; Thierry Touvier; Stefania Russo; Cristiana Perrotta; Vanina Romanello; Silvia Carnio; Valentina Cappello; Paolo Pellegrino; Claudia Moscheni; Maria Teresa Bassi; Marco Sandri; Davide Cervia; Emilio Clementi
Journal:  Skelet Muscle       Date:  2014-12-12       Impact factor: 4.912

Review 6.  Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

Authors:  Cara A Timpani; Alan Hayes; Emma Rybalka
Journal:  Orphanet J Rare Dis       Date:  2017-05-25       Impact factor: 4.123

7.  Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?

Authors:  Cara A Timpani; Kamel Mamchaoui; Gillian Butler-Browne; Emma Rybalka
Journal:  Antioxidants (Basel)       Date:  2020-12-13

Review 8.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

Review 9.  Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages.

Authors:  Gabriele Siciliano; Costanza Simoncini; Stefano Giannotti; Virna Zampa; Corrado Angelini; Giulia Ricci
Journal:  Acta Myol       Date:  2015-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.